Johnson & Johnson JNJ
$272.30
+0.40%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (12 Buy · 7 Hold · 0 Sell)
- Average Price Target
- $267.84
- Implied Upside
- -1.6%
- Price Target Range
- $208.00 – $320.00
- Analysts (12 mo)
- 19
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-10 | HSBCRajesh Kumar |
Maintains | Buy | $290 → $320 |
| 2026-09-02 | UBSMichael Yee |
Maintains | Buy | $280 → $320 |
| 2026-08-06 | GuggenheimVamil Divan |
Maintains | Buy | $270 → $287 |
| 2026-08-03 | Wells FargoLarry Biegelsen |
Maintains | Overweight | $272 → $282 |
| 2026-07-17 | GuggenheimVamil Divan |
Reiterates | Buy | $270 |
| 2026-07-16 | Raymond JamesJayson Bedford |
Maintains | Outperform | $258 → $265 |
| 2026-07-16 | RBC CapitalShagun Singh |
Reiterates | Outperform | $287 |
| 2026-07-16 | Wells FargoLarry Biegelsen |
Maintains | Overweight | $263 → $272 |
| 2026-07-16 | Morgan StanleyTerence Flynn |
Maintains | Overweight | $284 → $294 |
| 2026-07-13 | TD CowenMichael Nedelcovych |
Maintains | Buy | $250 → $300 |
| 2026-07-13 | RBC CapitalShagun Singh |
Maintains | Outperform | $265 → $287 |
| 2026-07-10 | B of A SecuritiesTim Anderson |
Maintains | Neutral | $254 → $263 |
| 2026-07-08 | Morgan StanleyTerence Flynn |
Maintains | Overweight | $283 → $284 |
| 2026-07-08 | CitigroupJoanne Wuensch |
Maintains | Buy | $285 → $298 |
| 2026-06-26 | GuggenheimVamil Divan |
Maintains | Buy | $266 → $270 |
| 2026-05-13 | Leerink PartnersDavid Risinger |
Upgrades | Market perform → Outperform | $265 |
| 2026-04-15 | BarclaysMatt Miksic |
Maintains | Equal-weight | $234 → $255 |
| 2026-04-15 | StifelRick Wise |
Maintains | Hold | $220 → $250 |
| 2026-04-15 | Wells FargoLarry Biegelsen |
Maintains | Overweight | $240 → $263 |
| 2026-04-10 | Morgan StanleyTerence Flynn |
Maintains | Overweight | $262 → $267 |
| 2026-04-08 | TD CowenMichael Nedelcovych |
Assumes | Buy | $250 |
| 2026-03-30 | RBC CapitalShagun Singh |
Reiterates | Outperform | $255 |
| 2026-03-19 | BarclaysMatt Miksic |
Maintains | Equal-weight | $217 → $234 |
| 2026-03-17 | HSBCMorten Herholdt |
Maintains | Buy | $265 → $280 |
| 2026-03-11 | CitigroupJoanne Wuensch |
Maintains | Buy | $250 → $274 |
| 2026-03-05 | JP MorganChris Schott |
Maintains | Neutral | $225 → $250 |
| 2026-02-03 | RBC CapitalShagun Singh |
Maintains | Outperform | $240 → $255 |
| 2026-01-28 | Morgan StanleyTerence Flynn |
Upgrades | Equal-weight → Overweight | $200 → $262 |
| 2026-01-27 | Freedom BrokerIlya Zubkov |
Maintains | Hold | $190 → $220 |
| 2026-01-27 | Freedom Capital MarketsIlya Zubkov |
Maintains | Hold | $190 → $220 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $272.30
- Market Cap
- $653.61 billion
- 52-Week Range
- $173.33 – $281.07
- Average Volume
- 6.26 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.